Acadia Pharmaceuticals (ACAD) Other Non Operating Income (2018 - 2026)
Acadia Pharmaceuticals' (ACAD) quarterly Other Non Operating Income came in at $542000.0 in Q1 2026, down 7.82% year-on-year from $588000.0 in Q1 2025, and down 93.86% quarter-over-quarter from $8.8 million in Q4 2025.
Acadia Pharmaceuticals (ACAD) Other Non Operating Income (2018 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Other Non Operating Income history runs 9 years deep, the most recent figure standing at $542000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 7.82% year-over-year to $542000.0 in Q1 2026; TTM through Mar 2026 was $10.6 million, a 396.66% increase from a year earlier, with the FY2025 full-year figure at $10.6 million, up 481.46% from the prior year.
- Other Non Operating Income fell to $542000.0 in Q1 2026 per ACAD's latest filing, from $8.8 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $8.8 million in Q4 2025 and bottomed at -$4.0 million in Q4 2022.
- The 5-year median for Other Non Operating Income is $576000.0 (2024), against an average of $989470.6.
- Across the five-year window, Other Non Operating Income sank 379.21% in 2022 and jumped 1434.78% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$4.0 million in 2022, then soared by 118.09% to $718000.0 in 2023, then slipped by 19.92% to $575000.0 in 2024, then soared by 1434.78% to $8.8 million in 2025, then slumped by 93.86% to $542000.0 in 2026.
- Per Business Quant, the three latest ACAD Other Non Operating Income figures stand at $542000.0 (Q1 2026), $8.8 million (Q4 2025), and $593000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 542,000.00 |
| Dec 31, 2025 | 8.83 Mn |
| Sep 30, 2025 | 593,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Mar 31, 2025 | 588,000.00 |
| Dec 31, 2024 | 575,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | 386,000.00 |
| Mar 31, 2024 | 286,000.00 |
| Dec 31, 2023 | 718,000.00 |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Mar 31, 2023 | 4.85 Mn |
| Dec 31, 2022 | -3.97 Mn |
| Sep 30, 2022 | 2.16 Mn |
| Jun 30, 2022 | -497,000.00 |
| Mar 31, 2022 | 340,000.00 |
| Dec 31, 2021 | -12.43 Mn |
| Sep 30, 2021 | 383,000.00 |
| Jun 30, 2021 | 178,000.00 |